XNAS · BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) · BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Amgen announced CFO Peter Griffith's retirement after six years in the role, with Thomas Dittrich set to take over as CFO on September 1, 2026. The transition is planned and structured, with Griffith staying throu…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 5/7/2026 | Bradway Robert A | Chairman, CEO and President | TAX_WITHHOLD | -2,079 | $331 | $688,378 |
| 5/7/2026 | Gordon Murdo | EVP, Global Commercial Ops | TAX_WITHHOLD | -615 | $331 | $203,633 |
| 5/7/2026 | Graham Jonathan P | EVP & Gen. Counsel & Sec. | TAX_WITHHOLD | -499 | $331 | $165,224 |
| 5/7/2026 | Griffith Peter H. | EVP & CFO | TAX_WITHHOLD | -556 | $331 | $184,097 |
| 5/7/2026 | Grygiel Nancy A. | SVP & CCO | TAX_WITHHOLD | -88 | $331 | $29,138 |
| 5/7/2026 | Khosla Rachna | SVP, Business Development | TAX_WITHHOLD | -93 | $331 | $30,793 |
| 5/7/2026 | Miller Derek | SVP, Human Resources | TAX_WITHHOLD | -151 | $331 | $49,998 |
| 5/7/2026 | REESE DAVID M | EVP & Chief Technology Officer | TAX_WITHHOLD | -556 | $331 | $184,097 |
| 5/7/2026 | Santos Esteban | EVP, Operations | TAX_WITHHOLD | -522 | $331 | $172,839 |
| 5/7/2026 | Busch Matthew C. | VP, Finance & CAO | TAX_WITHHOLD | -41 | $331 | $13,576 |
| 5/6/2026 | REESE DAVID M | EVP & Chief Technology Officer | TAX_WITHHOLD | -454 | $330 | $149,634 |
| 5/6/2026 | Miller Derek | SVP, Human Resources | TAX_WITHHOLD | -123 | $330 | $40,540 |
| 5/6/2026 | Khosla Rachna | SVP, Business Development | TAX_WITHHOLD | -79 | $330 | $26,038 |
| 5/6/2026 | Grygiel Nancy A. | SVP & CCO | TAX_WITHHOLD | -76 | $330 | $25,049 |
| 5/6/2026 | Griffith Peter H. | EVP & CFO | TAX_WITHHOLD | -502 | $330 | $165,454 |
| 5/6/2026 | Graham Jonathan P | EVP & Gen. Counsel & Sec. | TAX_WITHHOLD | -408 | $330 | $134,473 |
| 5/6/2026 | Gordon Murdo | EVP, Global Commercial Ops | TAX_WITHHOLD | -502 | $330 | $165,454 |
| 5/6/2026 | Busch Matthew C. | VP, Finance & CAO | TAX_WITHHOLD | -50 | $330 | $16,480 |
| 5/6/2026 | Bradway Robert A | Chairman, CEO and President | TAX_WITHHOLD | -1,702 | $330 | $560,962 |
| 5/6/2026 | Bradner James E. | EVP, Research and Development | TAX_WITHHOLD | -407 | $330 | $134,143 |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 5/4/2026 | Grygiel Nancy A. | — | 1,237 | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 54,838,826 | $17,949,296,138 | — | 1/29/2026 |
| BlackRock | 46,042,729 | $14,386,050,803 | — | 8/13/2024 |
| State Street | 30,591,403 | $10,012,872,116 | — | 2/13/2026 |
| Fidelity (FMR) | 3,592,220 | $1,175,769,605 | — | 2/17/2026 |
| JP Morgan Chase | 2,383,625 | $780,184,839 | — | 2/11/2026 |
| Citadel Advisors | 1,703,580 | $557,598,770 | — | 2/17/2026 |
| Two Sigma | 723,988 | $236,968,512 | — | 2/17/2026 |
| Millennium Management | 513,331 | $168,018,370 | — | 2/17/2026 |
| AQR Capital | 218,527 | $71,526,129 | — | 2/17/2026 |
| DE Shaw | 163,877 | $53,638,581 | — | 2/17/2026 |
| Point72 | 11,200 | $3,665,872 | — | 2/17/2026 |
| Bridgewater Associates | 3,020 | $988,476 | — | 2/13/2026 |